메뉴 건너뛰기




Volumn 26, Issue 9, 2014, Pages 581-596

The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies

Author keywords

Functional imaging; Oesophageal cancer; Pancreatic cancer; Radiotherapy treatment planning; Response assessment; Target volume delineation

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

EID: 84905572653     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.06.009     Document Type: Article
Times cited : (14)

References (69)
  • 1
    • 20244387586 scopus 로고    scopus 로고
    • Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
    • Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005, 23(10):2310-2317.
    • (2005) J Clin Oncol , vol.23 , Issue.10 , pp. 2310-2317
    • Stahl, M.1    Stuschke, M.2    Lehmann, N.3
  • 2
    • 0033526355 scopus 로고    scopus 로고
    • Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)
    • Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). J Am Med Assoc 1999, 281(17):1623-1627.
    • (1999) J Am Med Assoc , vol.281 , Issue.17 , pp. 1623-1627
    • Cooper, J.S.1    Guo, M.D.2    Herskovic, A.3
  • 3
    • 0036499029 scopus 로고    scopus 로고
    • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy
    • Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20(5):1167-1174.
    • (2002) J Clin Oncol , vol.20 , Issue.5 , pp. 1167-1174
    • Minsky, B.D.1    Pajak, T.F.2    Ginsberg, R.J.3
  • 4
    • 84860697144 scopus 로고    scopus 로고
    • Failure patterns in patients with esophageal cancer treated with definitive chemoradiation
    • Welsh J., Settle S.H., Amini A., et al. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 2012, 118(10):2632-2640.
    • (2012) Cancer , vol.118 , Issue.10 , pp. 2632-2640
    • Welsh, J.1    Settle, S.H.2    Amini, A.3
  • 5
    • 34548492286 scopus 로고    scopus 로고
    • Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma
    • Konski A.A., Cheng J.D., Goldberg M., et al. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys 2007, 69(2):358-363.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , Issue.2 , pp. 358-363
    • Konski, A.A.1    Cheng, J.D.2    Goldberg, M.3
  • 6
    • 84861679981 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy for esophageal or junctional cancer
    • Van Hagen P., Hulshof M.C.C.M., Van Lanschot J.J.B., et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012, 366(22):2074-2084.
    • (2012) N Engl J Med , vol.366 , Issue.22 , pp. 2074-2084
    • Van Hagen, P.1    Hulshof, M.C.C.M.2    Van Lanschot, J.J.B.3
  • 7
    • 33645468927 scopus 로고    scopus 로고
    • Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
    • Levine E.A., Farmer M.R., Clark P., et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006, 243(4):472-478.
    • (2006) Ann Surg , vol.243 , Issue.4 , pp. 472-478
    • Levine, E.A.1    Farmer, M.R.2    Clark, P.3
  • 8
    • 84863633198 scopus 로고    scopus 로고
    • Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French Consensus Recommendations
    • Huguet F., Goodman K.A., Azria D., Racadot S., Abrams R.A. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French Consensus Recommendations. Int J Radiat Oncol Biol Phys 2012, 83(5):1355-1364.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.5 , pp. 1355-1364
    • Huguet, F.1    Goodman, K.A.2    Azria, D.3    Racadot, S.4    Abrams, R.A.5
  • 9
    • 84884556143 scopus 로고    scopus 로고
    • Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study
    • abstract LBA4003
    • Hammel P. Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study. J Clin Oncol 2013, 31(Suppl.). abstract LBA4003.
    • (2013) J Clin Oncol , vol.31 , Issue.SUPPL.
    • Hammel, P.1
  • 10
    • 80051613675 scopus 로고    scopus 로고
    • Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression
    • Crane C.H., Varadhachary G.R., Yordy J.S., et al. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 2011, 29(22):3037-3043.
    • (2011) J Clin Oncol , vol.29 , Issue.22 , pp. 3037-3043
    • Crane, C.H.1    Varadhachary, G.R.2    Yordy, J.S.3
  • 11
    • 34250829023 scopus 로고    scopus 로고
    • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
    • Krishnan S., Rana V., Janjan N.A., et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 2007, 110(1):47-55.
    • (2007) Cancer , vol.110 , Issue.1 , pp. 47-55
    • Krishnan, S.1    Rana, V.2    Janjan, N.A.3
  • 12
    • 84873278759 scopus 로고    scopus 로고
    • Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer
    • Kelly P., Das P., Pinnix C.C., et al. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2013, 85(3):e143-e149.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.3
    • Kelly, P.1    Das, P.2    Pinnix, C.C.3
  • 13
    • 20244385572 scopus 로고    scopus 로고
    • Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
    • White R.R., Xie H.B., Gottfried M.R., et al. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol 2005, 12(3):214-221.
    • (2005) Ann Surg Oncol , vol.12 , Issue.3 , pp. 214-221
    • White, R.R.1    Xie, H.B.2    Gottfried, M.R.3
  • 14
    • 79957960722 scopus 로고    scopus 로고
    • Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer
    • Aoyagi T., Shuto K., Okazumi S., Shimada H., Kazama T., Matsubara H. Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Digest Surg 2011, 28(4):252-257.
    • (2011) Digest Surg , vol.28 , Issue.4 , pp. 252-257
    • Aoyagi, T.1    Shuto, K.2    Okazumi, S.3    Shimada, H.4    Kazama, T.5    Matsubara, H.6
  • 15
    • 84855769842 scopus 로고    scopus 로고
    • Measuring tumor hypoxia with 8F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study
    • Yue J., Yang Y., Cabrera A.R., et al. Measuring tumor hypoxia with 8F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study. Dis Esoph 2012, 25(1):54-61.
    • (2012) Dis Esoph , vol.25 , Issue.1 , pp. 54-61
    • Yue, J.1    Yang, Y.2    Cabrera, A.R.3
  • 16
    • 44449160438 scopus 로고    scopus 로고
    • Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience
    • Oberholzer K., Pohlmann A., Schreiber W., et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 2008, 27(6):1296-1301.
    • (2008) J Magn Reson Imaging , vol.27 , Issue.6 , pp. 1296-1301
    • Oberholzer, K.1    Pohlmann, A.2    Schreiber, W.3
  • 17
    • 79952788113 scopus 로고    scopus 로고
    • Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer
    • Tixier F., Le Rest C.C., Hatt M., et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 2011, 52(3):369-378.
    • (2011) J Nucl Med , vol.52 , Issue.3 , pp. 369-378
    • Tixier, F.1    Le Rest, C.C.2    Hatt, M.3
  • 18
    • 1542503721 scopus 로고    scopus 로고
    • Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
    • Wieder H.A., Brucher B.L.D.M., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004, 22(5):900-908.
    • (2004) J Clin Oncol , vol.22 , Issue.5 , pp. 900-908
    • Wieder, H.A.1    Brucher, B.L.D.M.2    Zimmermann, F.3
  • 19
    • 78651325646 scopus 로고    scopus 로고
    • Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus
    • Malik V., Lucey J.A., Duffy G.J., et al. Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus. J Nucl Med 2010, 51(12):1863-1869.
    • (2010) J Nucl Med , vol.51 , Issue.12 , pp. 1863-1869
    • Malik, V.1    Lucey, J.A.2    Duffy, G.J.3
  • 20
    • 78751627736 scopus 로고    scopus 로고
    • Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer
    • van Heijl M., Omloo J.M., van Berge Henegouwen M.I., et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 2011, 253(1):56-63.
    • (2011) Ann Surg , vol.253 , Issue.1 , pp. 56-63
    • van Heijl, M.1    Omloo, J.M.2    van Berge Henegouwen, M.I.3
  • 21
    • 84881637328 scopus 로고    scopus 로고
    • The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)
    • Palie O., Michel P., Maynard J.F., et al. The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imag 2013, 40(9):1345-1355.
    • (2013) Eur J Nucl Med Mol Imag , vol.40 , Issue.9 , pp. 1345-1355
    • Palie, O.1    Michel, P.2    Maynard, J.F.3
  • 22
    • 0036018910 scopus 로고    scopus 로고
    • Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
    • Flamen P., Van Cutsem E., Lerut A., et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002, 13(3):361-368.
    • (2002) Ann Oncol , vol.13 , Issue.3 , pp. 361-368
    • Flamen, P.1    Van Cutsem, E.2    Lerut, A.3
  • 23
    • 4744354764 scopus 로고    scopus 로고
    • 2-Fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
    • Swisher S.G., Erasmus J., Maish M., et al. 2-Fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004, 101(8):1776-1785.
    • (2004) Cancer , vol.101 , Issue.8 , pp. 1776-1785
    • Swisher, S.G.1    Erasmus, J.2    Maish, M.3
  • 24
    • 27144493390 scopus 로고    scopus 로고
    • FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer
    • Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 2005, 63(4):1053-1059.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , Issue.4 , pp. 1053-1059
    • Song, S.Y.1    Kim, J.H.2    Ryu, J.S.3
  • 25
    • 34249899397 scopus 로고    scopus 로고
    • Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
    • Kim M.K., Ryu J.-S., Kim S.-B., et al. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Eur J Cancer 2007, 43(9):1385-1391.
    • (2007) Eur J Cancer , vol.43 , Issue.9 , pp. 1385-1391
    • Kim, M.K.1    Ryu, J.-S.2    Kim, S.-B.3
  • 26
    • 34548463451 scopus 로고    scopus 로고
    • FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results
    • Mamede M., Abreu-E-Lima P., Oliva M.R., Nose V., Mamon H., Gerbaudo V.H. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol 2007, 30(4):377-388.
    • (2007) Am J Clin Oncol , vol.30 , Issue.4 , pp. 377-388
    • Mamede, M.1    Abreu-E-Lima, P.2    Oliva, M.R.3    Nose, V.4    Mamon, H.5    Gerbaudo, V.H.6
  • 27
    • 39049099397 scopus 로고    scopus 로고
    • Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus
    • Smithers B.M., Couper G.C., Thomas J.M., et al. Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. Dis Esoph 2008, 21(2):151-158.
    • (2008) Dis Esoph , vol.21 , Issue.2 , pp. 151-158
    • Smithers, B.M.1    Couper, G.C.2    Thomas, J.M.3
  • 28
    • 56949099284 scopus 로고    scopus 로고
    • Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation
    • Roedl J.B., Colen R.R., Holalkere N.S., Fischman A.J., Choi N.C., Blake M.A. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol 2008, 89(3):278-286.
    • (2008) Radiother Oncol , vol.89 , Issue.3 , pp. 278-286
    • Roedl, J.B.1    Colen, R.R.2    Holalkere, N.S.3    Fischman, A.J.4    Choi, N.C.5    Blake, M.A.6
  • 29
    • 52049112795 scopus 로고    scopus 로고
    • Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography
    • Roedl J.B., Harisinghani M.G., Colen R.R., et al. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thoracic Surg 2008, 86(4):1131-1138.
    • (2008) Ann Thoracic Surg , vol.86 , Issue.4 , pp. 1131-1138
    • Roedl, J.B.1    Harisinghani, M.G.2    Colen, R.R.3
  • 30
    • 60949088038 scopus 로고    scopus 로고
    • Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders
    • Cerfolio R.J., Bryant A.S., Talati A.A., et al. Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders. J Thorac Cardiovasc Surg 2009, 137:605-609.
    • (2009) J Thorac Cardiovasc Surg , vol.137 , pp. 605-609
    • Cerfolio, R.J.1    Bryant, A.S.2    Talati, A.A.3
  • 31
    • 59449097399 scopus 로고    scopus 로고
    • Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
    • Roedl J.B., Halpern E.F., Colen R.R., Sahani D.V., Fischman A.J., Blake M.A. Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol 2009, 11(1):54-60.
    • (2009) Mol Imaging Biol , vol.11 , Issue.1 , pp. 54-60
    • Roedl, J.B.1    Halpern, E.F.2    Colen, R.R.3    Sahani, D.V.4    Fischman, A.J.5    Blake, M.A.6
  • 32
    • 64649094846 scopus 로고    scopus 로고
    • Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy
    • erratum 2009;36(5):800
    • Schmidt M., Bollschweiler E., Dietlein M., et al. Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imag 2009, 36(5):735-744. erratum 2009;36(5):800.
    • (2009) Eur J Nucl Med Mol Imag , vol.36 , Issue.5 , pp. 735-744
    • Schmidt, M.1    Bollschweiler, E.2    Dietlein, M.3
  • 33
    • 84865627144 scopus 로고    scopus 로고
    • Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer
    • Jayachandran P., Pai R.K., Quon A., et al. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. Int J Radiat Oncol Biol Phys 2012, 84(2):471-477.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.2 , pp. 471-477
    • Jayachandran, P.1    Pai, R.K.2    Quon, A.3
  • 34
    • 84880311768 scopus 로고    scopus 로고
    • Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma
    • Ma J.-B., Chen E.-C., Song Y.-P., et al. Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma. Asian Pacific J Cancer Prevent 2013, 14(4):2477-2481.
    • (2013) Asian Pacific J Cancer Prevent , vol.14 , Issue.4 , pp. 2477-2481
    • Ma, J.-B.1    Chen, E.-C.2    Song, Y.-P.3
  • 35
    • 84879105617 scopus 로고    scopus 로고
    • Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer
    • Piessen G., Petyt G., Duhamel A., et al. Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2013, 258:66-76.
    • (2013) Ann Surg , vol.258 , pp. 66-76
    • Piessen, G.1    Petyt, G.2    Duhamel, A.3
  • 36
    • 84875234484 scopus 로고    scopus 로고
    • Spatial-temporal [8F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy
    • Tan S., Kligerman S., Chen W., et al. Spatial-temporal [8F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys 2013, 85(5):1375-1382.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.5 , pp. 1375-1382
    • Tan, S.1    Kligerman, S.2    Chen, W.3
  • 37
    • 26444557983 scopus 로고    scopus 로고
    • Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma
    • Hong D., Lunagomez S., Kim E.E., et al. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 2005, 104:1620-1626.
    • (2005) Cancer , vol.104 , pp. 1620-1626
    • Hong, D.1    Lunagomez, S.2    Kim, E.E.3
  • 38
    • 79958045458 scopus 로고    scopus 로고
    • Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology
    • Hatt M., Visvikis D., Albarghach N.M., Tixier F., Pradier O., Cheze-le Rest C. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging 2011, 38(7):1191-1202.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , Issue.7 , pp. 1191-1202
    • Hatt, M.1    Visvikis, D.2    Albarghach, N.M.3    Tixier, F.4    Pradier, O.5    Cheze-le Rest, C.6
  • 39
    • 80054800344 scopus 로고    scopus 로고
    • Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy
    • Suzuki A., Xiao L., Hayashi Y., et al. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 2011, 117(21):4823-4833.
    • (2011) Cancer , vol.117 , Issue.21 , pp. 4823-4833
    • Suzuki, A.1    Xiao, L.2    Hayashi, Y.3
  • 40
    • 84882264488 scopus 로고    scopus 로고
    • Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas
    • Cuenca X., Hennequin C., Hindie E., et al. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas. Eur J Nucl Med Mol Imaging 2013, 40(4):477-485.
    • (2013) Eur J Nucl Med Mol Imaging , vol.40 , Issue.4 , pp. 477-485
    • Cuenca, X.1    Hennequin, C.2    Hindie, E.3
  • 41
    • 84865760934 scopus 로고    scopus 로고
    • 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma
    • Di Fiore F., Blondin V., Hitzel A., et al. 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma. Digest Liver Dis 2012, 44(10):875-879.
    • (2012) Digest Liver Dis , vol.44 , Issue.10 , pp. 875-879
    • Di Fiore, F.1    Blondin, V.2    Hitzel, A.3
  • 42
    • 84905570840 scopus 로고    scopus 로고
    • Duong
    • Duong 2006.
    • (2006)
  • 43
    • 78149325746 scopus 로고    scopus 로고
    • Outcomes of patients with esophageal cancer staged with [8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
    • Monjazeb A.M., Riedlinger G., Aklilu M., et al. Outcomes of patients with esophageal cancer staged with [8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?. J Clin Oncol 2010, 28(31):4714-4721.
    • (2010) J Clin Oncol , vol.28 , Issue.31 , pp. 4714-4721
    • Monjazeb, A.M.1    Riedlinger, G.2    Aklilu, M.3
  • 44
    • 84871924926 scopus 로고    scopus 로고
    • Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting the pathologic response to preoperative chemoradiation therapy in patients with resectable T3 pancreatic cancer
    • Kittaka H., Takahashi H., Ohigashi H., et al. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting the pathologic response to preoperative chemoradiation therapy in patients with resectable T3 pancreatic cancer. World J Surg 2013, 37(1):169-178.
    • (2013) World J Surg , vol.37 , Issue.1 , pp. 169-178
    • Kittaka, H.1    Takahashi, H.2    Ohigashi, H.3
  • 45
    • 33749245830 scopus 로고    scopus 로고
    • Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer
    • Maemura K., Takao S., Shinchi H., et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 2006, 13:435-441.
    • (2006) J Hepatobiliary Pancreat Surg , vol.13 , pp. 435-441
    • Maemura, K.1    Takao, S.2    Shinchi, H.3
  • 46
    • 33750615837 scopus 로고    scopus 로고
    • The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer
    • Bang S., Chung H.W., Park S.W., et al. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterology 2006, 40:923-929.
    • (2006) J Clin Gastroenterology , vol.40 , pp. 923-929
    • Bang, S.1    Chung, H.W.2    Park, S.W.3
  • 47
    • 80755125824 scopus 로고    scopus 로고
    • Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
    • Topkan E., Parlak C., Kotek A., Yapar A.F., Pehlivan B. Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC Gastroenterol 2011, 11.
    • (2011) BMC Gastroenterol , vol.11
    • Topkan, E.1    Parlak, C.2    Kotek, A.3    Yapar, A.F.4    Pehlivan, B.5
  • 48
    • 84858300680 scopus 로고    scopus 로고
    • Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
    • Parlak C., Topkan E., Onal C., Reyhan M., Selek U. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiat Oncol 2012, 7.
    • (2012) Radiat Oncol , vol.7
    • Parlak, C.1    Topkan, E.2    Onal, C.3    Reyhan, M.4    Selek, U.5
  • 49
    • 2542636369 scopus 로고    scopus 로고
    • Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma
    • Brink I., Hentschel M., Bley T.A., et al. Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol 2004, 30(5):544-550.
    • (2004) Eur J Surg Oncol , vol.30 , Issue.5 , pp. 544-550
    • Brink, I.1    Hentschel, M.2    Bley, T.A.3
  • 50
    • 35448953999 scopus 로고    scopus 로고
    • Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers
    • Makari Y., Yasuda T., Doki Y., et al. Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol 2007, 96(3):220-229.
    • (2007) J Surg Oncol , vol.96 , Issue.3 , pp. 220-229
    • Makari, Y.1    Yasuda, T.2    Doki, Y.3
  • 51
    • 70449652458 scopus 로고    scopus 로고
    • Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer
    • Muijs C.T., Schreurs L.M., Busz D.M., et al. Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. Radiother Oncol 2009, 93(3):447-453.
    • (2009) Radiother Oncol , vol.93 , Issue.3 , pp. 447-453
    • Muijs, C.T.1    Schreurs, L.M.2    Busz, D.M.3
  • 52
    • 33845671751 scopus 로고    scopus 로고
    • Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer
    • Gondi V., Bradley K., Mehta M., et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 67(1):187-195.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , Issue.1 , pp. 187-195
    • Gondi, V.1    Bradley, K.2    Mehta, M.3
  • 53
    • 14844295774 scopus 로고    scopus 로고
    • The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma
    • Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2005, 61(4):1123-1128.
    • (2005) Int J Radiat Oncol Biol Phys , vol.61 , Issue.4 , pp. 1123-1128
    • Konski, A.1    Doss, M.2    Milestone, B.3
  • 54
    • 77956009133 scopus 로고    scopus 로고
    • Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability
    • Schreurs L.M.A., Busz D.M., Paardekooper G.M.R.M., et al. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability. Dis Esoph 2010, 23(6):493-501.
    • (2010) Dis Esoph , vol.23 , Issue.6 , pp. 493-501
    • Schreurs, L.M.A.1    Busz, D.M.2    Paardekooper, G.M.R.M.3
  • 55
    • 56349094350 scopus 로고    scopus 로고
    • Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning
    • Hong T.S., Killoran J.H., Mamede M., Mamon H.J. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys 2008, 72(5):1612-1618.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.5 , pp. 1612-1618
    • Hong, T.S.1    Killoran, J.H.2    Mamede, M.3    Mamon, H.J.4
  • 56
    • 24944444211 scopus 로고    scopus 로고
    • Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma
    • Moureau-Zabotto L., Touboul E., Lerouge D., et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 2005, 63(2):340-345.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , Issue.2 , pp. 340-345
    • Moureau-Zabotto, L.1    Touboul, E.2    Lerouge, D.3
  • 57
    • 51249089233 scopus 로고    scopus 로고
    • Improving observer variability in target delineation for gastro-oesophageal cancer-the role of 18ffluoro-2-deoxy-d-glucose positron emission tomography/computed tomography
    • Vesprini D., Ung Y., Dinniwell R., et al. Improving observer variability in target delineation for gastro-oesophageal cancer-the role of 18ffluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Clin Oncol 2008, 20(8):631-638.
    • (2008) Clin Oncol , vol.20 , Issue.8 , pp. 631-638
    • Vesprini, D.1    Ung, Y.2    Dinniwell, R.3
  • 58
    • 81855175299 scopus 로고    scopus 로고
    • A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus
    • Yu W., Fu X.-L., Zhang Y.-J., Xiang J.-Q., Shen L., Chang J.Y. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys 2011, 81(5):e759-e765.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.5
    • Yu, W.1    Fu, X.-L.2    Zhang, Y.-J.3    Xiang, J.-Q.4    Shen, L.5    Chang, J.Y.6
  • 59
    • 84876140652 scopus 로고    scopus 로고
    • Oesophageal tumour progression between the diagnostic 8F-FDG-PET and the 8F-FDG-PET for radiotherapy treatment planning
    • Muijs C.T., Pruim J., Beukema J.C., Berveling M.J., Plukker J.T., Langendijk J.A. Oesophageal tumour progression between the diagnostic 8F-FDG-PET and the 8F-FDG-PET for radiotherapy treatment planning. Radiother Oncol 2013, 106(3):283-287.
    • (2013) Radiother Oncol , vol.106 , Issue.3 , pp. 283-287
    • Muijs, C.T.1    Pruim, J.2    Beukema, J.C.3    Berveling, M.J.4    Plukker, J.T.5    Langendijk, J.A.6
  • 60
    • 70549103329 scopus 로고    scopus 로고
    • GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer
    • Yu W., Fu X.L., Zhang Y.J., et al. GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer. Radiother Oncol 2009, 93(3):441-446.
    • (2009) Radiother Oncol , vol.93 , Issue.3 , pp. 441-446
    • Yu, W.1    Fu, X.L.2    Zhang, Y.J.3
  • 61
    • 57649112364 scopus 로고    scopus 로고
    • Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus
    • Zhong X., Yu J., Zhang B., et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009, 73(1):136-141.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , Issue.1 , pp. 136-141
    • Zhong, X.1    Yu, J.2    Zhang, B.3
  • 62
    • 84872108446 scopus 로고    scopus 로고
    • The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer
    • Wang Y.-C., Hsieh T.-C., Yu C.-Y., et al. The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer. J Radiat Res 2012, 53(4):594-600.
    • (2012) J Radiat Res , vol.53 , Issue.4 , pp. 594-600
    • Wang, Y.-C.1    Hsieh, T.-C.2    Yu, C.-Y.3
  • 63
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors
    • Wahl R.L., Jacene H., Kasamon Y., Lodge M.A. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009, 50(Suppl. 1):122S-150S.
    • (2009) J Nucl Med , vol.50 , Issue.SUPPL. 1
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 64
    • 84890559948 scopus 로고    scopus 로고
    • Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics
    • Zhang H., Tan S., Chen W., et al. Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics. Int J Radiat Oncol Biol Phys 2014, 88(1):195-203.
    • (2014) Int J Radiat Oncol Biol Phys , vol.88 , Issue.1 , pp. 195-203
    • Zhang, H.1    Tan, S.2    Chen, W.3
  • 65
    • 1842376309 scopus 로고    scopus 로고
    • Early changes in fluorine-18-FDG uptake during radiotherapy
    • Hautzel H., Müller-Gärtner H.W. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997, 38(9):1384-1386.
    • (1997) J Nucl Med , vol.38 , Issue.9 , pp. 1384-1386
    • Hautzel, H.1    Müller-Gärtner, H.W.2
  • 66
    • 0035282748 scopus 로고    scopus 로고
    • Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies
    • Hirota S., Tsujino K., Hishikawa Y., et al. Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol 2001, 58(3):273-278.
    • (2001) Radiother Oncol , vol.58 , Issue.3 , pp. 273-278
    • Hirota, S.1    Tsujino, K.2    Hishikawa, Y.3
  • 67
    • 34250369252 scopus 로고    scopus 로고
    • Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice
    • Schütze C., Bergmann R., Yaromina A., et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol 2007, 83(3):311-315.
    • (2007) Radiother Oncol , vol.83 , Issue.3 , pp. 311-315
    • Schütze, C.1    Bergmann, R.2    Yaromina, A.3
  • 68
    • 33748049814 scopus 로고    scopus 로고
    • Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models
    • Apisarnthanarax S., Alauddin M.M., Mourtada F., et al. Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models. Clin Cancer Res 2006, 12(15):4590-4597.
    • (2006) Clin Cancer Res , vol.12 , Issue.15 , pp. 4590-4597
    • Apisarnthanarax, S.1    Alauddin, M.M.2    Mourtada, F.3
  • 69
    • 78650814437 scopus 로고    scopus 로고
    • Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer
    • Yamashita H., Kida S., Sakumi A., et al. Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer. Int J Radiat Oncol Biol Phys 2011, 79(2):588-595.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.2 , pp. 588-595
    • Yamashita, H.1    Kida, S.2    Sakumi, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.